CY1124796T1 - Παραγωγης υψηλης-καθαροτητας των πρωτεϊνων πολλαπλων-υπομοναδων οπως ειναι τα αντισωματα σε μετασχηματισθεντα μικροβια οπως ειναι to pichia pastoris - Google Patents

Παραγωγης υψηλης-καθαροτητας των πρωτεϊνων πολλαπλων-υπομοναδων οπως ειναι τα αντισωματα σε μετασχηματισθεντα μικροβια οπως ειναι to pichia pastoris

Info

Publication number
CY1124796T1
CY1124796T1 CY20211101055T CY211101055T CY1124796T1 CY 1124796 T1 CY1124796 T1 CY 1124796T1 CY 20211101055 T CY20211101055 T CY 20211101055T CY 211101055 T CY211101055 T CY 211101055T CY 1124796 T1 CY1124796 T1 CY 1124796T1
Authority
CY
Cyprus
Prior art keywords
subunit proteins
pichia pastoris
antibodies
purity production
transformed microbes
Prior art date
Application number
CY20211101055T
Other languages
Greek (el)
English (en)
Inventor
Nicole Janson
Gary L Lesnicki
Pei Qi
Patricia Dianne Mcneill
John A. Latham
Leon F. Garcia-Martinez
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of CY1124796T1 publication Critical patent/CY1124796T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • C12N1/18Baker's yeast; Brewer's yeast
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
CY20211101055T 2011-05-20 2021-12-02 Παραγωγης υψηλης-καθαροτητας των πρωτεϊνων πολλαπλων-υπομοναδων οπως ειναι τα αντισωματα σε μετασχηματισθεντα μικροβια οπως ειναι to pichia pastoris CY1124796T1 (el)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161488660P 2011-05-20 2011-05-20
US201161496860P 2011-06-14 2011-06-14
US201161496873P 2011-06-14 2011-06-14
US201161525307P 2011-08-19 2011-08-19
PCT/US2012/036953 WO2012161956A2 (en) 2011-05-20 2012-05-08 High-purity production of multi-subunit proteins such as antibodies in transformed microbes such as pichia pastoris

Publications (1)

Publication Number Publication Date
CY1124796T1 true CY1124796T1 (el) 2022-11-25

Family

ID=47217961

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20211101055T CY1124796T1 (el) 2011-05-20 2021-12-02 Παραγωγης υψηλης-καθαροτητας των πρωτεϊνων πολλαπλων-υπομοναδων οπως ειναι τα αντισωματα σε μετασχηματισθεντα μικροβια οπως ειναι to pichia pastoris

Country Status (22)

Country Link
EP (1) EP2710114B1 (cg-RX-API-DMAC7.html)
JP (2) JP6193220B2 (cg-RX-API-DMAC7.html)
KR (1) KR101981662B1 (cg-RX-API-DMAC7.html)
CN (2) CN103827290A (cg-RX-API-DMAC7.html)
BR (1) BR112013029902A2 (cg-RX-API-DMAC7.html)
CA (1) CA2837000C (cg-RX-API-DMAC7.html)
CY (1) CY1124796T1 (cg-RX-API-DMAC7.html)
DK (1) DK2710114T3 (cg-RX-API-DMAC7.html)
EA (1) EA028913B9 (cg-RX-API-DMAC7.html)
ES (1) ES2899381T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20211873T1 (cg-RX-API-DMAC7.html)
HU (1) HUE060418T2 (cg-RX-API-DMAC7.html)
IL (1) IL229430B (cg-RX-API-DMAC7.html)
LT (1) LT2710114T (cg-RX-API-DMAC7.html)
MX (2) MX368546B (cg-RX-API-DMAC7.html)
PL (1) PL2710114T3 (cg-RX-API-DMAC7.html)
PT (1) PT2710114T (cg-RX-API-DMAC7.html)
RS (1) RS62628B1 (cg-RX-API-DMAC7.html)
SG (1) SG194937A1 (cg-RX-API-DMAC7.html)
SI (1) SI2710114T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202100677T1 (cg-RX-API-DMAC7.html)
WO (1) WO2012161956A2 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111973740A (zh) * 2014-03-21 2020-11-24 泰华制药国际有限公司 针对降钙素基因相关肽的拮抗剂抗体及其使用方法
TWI734775B (zh) 2016-04-26 2021-08-01 美商美國泰福生技股份有限公司 細胞培養基
CN109952314A (zh) 2016-09-23 2019-06-28 泰瓦制药国际有限公司 治疗难治性偏头痛
GB201803832D0 (en) * 2018-03-09 2018-04-25 Syndermix Ag Methods and compositions for lectin production
CN108913732B (zh) * 2018-07-31 2022-02-08 华东理工大学 一种莫纳可林j异源生产的方法及应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
WO1994021293A1 (en) 1993-03-19 1994-09-29 Duke University Method of treatment of tumors with an antibody binding to tenascin
ATE306930T1 (de) 1994-08-12 2005-11-15 Immunomedics Inc Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
US5955349A (en) 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
US5736383A (en) 1996-08-26 1998-04-07 Zymogenetics, Inc. Preparation of Pichia methanolica auxotrophic mutants
US6653104B2 (en) 1996-10-17 2003-11-25 Immunomedics, Inc. Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
US6730499B1 (en) 1998-07-03 2004-05-04 Research Corporation Technologies, Inc. Promoter for the Pichia pastoris formaldehyde dehydrogenase gene FLD1
AU3910000A (en) * 1999-03-22 2000-10-09 Zymogenetics Inc. Improved methods for producing proteins in transformed (pichia)
US6258559B1 (en) 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
CA2427665C (en) * 2000-12-13 2011-10-11 Unilever Plc Method for the production of a heterologous protein by a fungus
NZ547279A (en) 2003-10-22 2008-04-30 Keck Graduate Inst Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
US8222386B2 (en) * 2006-10-10 2012-07-17 Keck Graduate Institute P. pastoris ADH promoter and use thereof to direct expression of proteins
CN105001332B (zh) 2007-05-21 2018-12-04 奥尔德生物控股有限责任公司 针对il-6的抗体及其用途
EP2162469A4 (en) 2007-05-21 2012-08-01 Alderbio Holdings Llc NEW METHODS OF HUMANIZING RABBIT ANTIBODIES AND HUMANIZED RABBIT ANTIBODIES
MX359070B (es) * 2010-12-01 2018-09-13 Alderbio Holdings Llc Composiciones anti-ngf y uso de las mismas.

Also Published As

Publication number Publication date
WO2012161956A3 (en) 2013-01-17
SMT202100677T1 (it) 2022-01-10
SI2710114T1 (sl) 2022-01-31
DK2710114T3 (da) 2021-12-06
RS62628B1 (sr) 2021-12-31
WO2012161956A2 (en) 2012-11-29
CA2837000A1 (en) 2012-11-29
IL229430B (en) 2020-07-30
JP6491696B2 (ja) 2019-03-27
CN103827290A (zh) 2014-05-28
NZ718187A (en) 2017-10-27
ES2899381T3 (es) 2022-03-11
CN110408644A (zh) 2019-11-05
KR101981662B1 (ko) 2019-05-23
JP2014517698A (ja) 2014-07-24
PL2710114T3 (pl) 2022-01-17
MX2013013532A (es) 2015-08-20
EP2710114B1 (en) 2021-11-03
SG194937A1 (en) 2013-12-30
EP2710114A4 (en) 2014-11-19
WO2012161956A9 (en) 2013-09-06
EP2710114A2 (en) 2014-03-26
MX368546B (es) 2019-10-07
KR20140033445A (ko) 2014-03-18
EA201301294A1 (ru) 2014-05-30
CA2837000C (en) 2021-09-14
EA028913B9 (ru) 2018-03-30
MX2019012022A (es) 2019-11-18
LT2710114T (lt) 2021-12-10
NZ618635A (en) 2016-09-30
EA028913B1 (ru) 2018-01-31
JP6193220B2 (ja) 2017-09-06
JP2018007656A (ja) 2018-01-18
HRP20211873T1 (hr) 2022-03-04
HUE060418T2 (hu) 2023-02-28
BR112013029902A2 (pt) 2016-12-20
IL229430A0 (en) 2014-01-30
PT2710114T (pt) 2021-12-09

Similar Documents

Publication Publication Date Title
CY1124796T1 (el) Παραγωγης υψηλης-καθαροτητας των πρωτεϊνων πολλαπλων-υπομοναδων οπως ειναι τα αντισωματα σε μετασχηματισθεντα μικροβια οπως ειναι to pichia pastoris
MX384491B (es) Cambio de temperatura para una expresion con mayor rendimiento de polipeptidos en levaduras y otras celulas transformadas.
CY1121862T1 (el) Αντισωματα anti-phf-tau και χρησεις αυτων
CL2018002852A1 (es) Producción celular de ácido ribonucleico
CR20150258A (es) Anticuerpos anti-ceacam5 y usos de éstos
MX2014001951A (es) Estrategia de multiples copias para produccion de alto titulo y alta pureza de proteinas de multi-subunidades tales como anticuerpos en microbios transformados tal como pichia pastoris.
CY1119055T1 (el) Αντισωματα που προσδενονται στην il-17a και στην il-17f
CY1120471T1 (el) Αντισωματα κατα του cd70
MX375524B (es) Anticuerpos anti-axl.
EA201101306A1 (ru) Способ повышения выхода полипептидов
FR2991999B1 (fr) Methode de fabrication de nanofils de cuscn par voie electrochimique
CY1119173T1 (el) Νεα μορια αναστολεα jnk
MY181068A (en) Recombinant microorganism for improved production of fine chemicals
BR112013027641A2 (pt) processo verde para produzir poli-hidroxialcanoatos e produtos químicos com o uso de uma matéria-prima renovável
PH12016501094A1 (en) Recombinant microorganism for improved production of fine chemicals
WO2011146527A3 (en) Mammalian genes involved in infection
WO2014182684A3 (en) Methods and compositions related to large scale production of proteins
CY1121055T1 (el) Μεθοδος για την παρασκευη φορτισμενων διασυνδετων
BR112015007830A2 (pt) aumento do rendimento para plantas suscetíveis ao estresse
MX372971B (es) Sintesis de trans-8-cloro-5-metil-1-[4-(piridin-2-iloxi)-ciclohexil]-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo[e]azuleno y formas cristalinas del mismo.
EP2925879A4 (en) IMPROVED CULTIVATION MEDIUM AND METHOD FOR IMPROVED PROTEIN MANUFACTURE BY PICHIA STRAINS
MY184085A (en) Method of protein manufacture
CY1121351T1 (el) Μεθοδος για την παρασκευη οξυκωδονης
WO2014044626A3 (en) Process for producing gelatin employing aspergillopepsin ii
MX386674B (es) Produccion de anticuerpos ex vivo.